Evotec shuts down IT sys­tems in wake of cy­ber­at­tack

3 years ago
Pharma

VC trio de­buts seed fund; Take­da cuts ear­ly gene ther­a­py work; Bio­gen’s new face of BD; Biotech in­vestors get hands ...

3 years ago
Weekly

Phar­ma and health­care judges named for Cannes Li­ons ad­ver­tis­ing cre­ativ­i­ty awards

3 years ago
Pharma
Marketing

Sam­sung and San­doz ques­tion FDA's 're­search roadmap' for biosim­i­lars de­vel­op­ment

3 years ago
Pharma
FDA+

GSK must pay As­traZeneca roy­al­ties on Ze­ju­la, UK court rules

3 years ago
Pharma
Law

Wash­ing­ton state stock­piles med­ical abor­tion drug ahead of ex­pect­ed court de­ci­sion

3 years ago
Pharma

Re­al Chem­istry teams with stock pho­to spe­cial­ist to boost di­verse im­ages in phar­ma mar­ket­ing

3 years ago
Pharma
Marketing

Con­tract man­u­fac­tur­er Phlow rais­es $36M to build out ser­vices

3 years ago
Financing
Pharma

Man­u­fac­tur­ing roundup: In­vest­ment firm buys Pfiz­er fa­cil­i­ty in Aus­tralia; Cam­brex opens new fa­cil­i­ty in Bel­gium

3 years ago
Manufacturing

Pep­tide man­u­fac­tur­er Mytide Ther­a­peu­tics names Mar­ti­na Diek­mann as CEO

3 years ago
People
Manufacturing

Im­mu­nic touts pos­i­tive da­ta in main­te­nance phase of failed PhII tri­al, pulls back on an­oth­er as­set

3 years ago
R&D

Pri­vate start­up claims a PhI­Ia win in sub­set of ALS pa­tients, but ques­tions re­main

3 years ago
R&D

Take­da end­ing dis­cov­ery, pre­clin­i­cal work in AAV gene ther­a­py, rare hema­tol­ogy

3 years ago
People
R&D

AI tools don't equal guar­an­teed drug suc­cess as Benev­o­len­tAI flops der­mati­tis test

3 years ago
R&D
AI

FDA fi­nal­ly de­cides to pull preterm birth drug Mak­e­na — ef­fec­tive im­me­di­ate­ly

3 years ago
FDA+

Cell ther­a­py biotech Ser­no­va re­sponds to board nom­i­nees from 'con­cerned share­hold­er­s'

3 years ago
People

Quince Ther­a­peu­tics sets up poi­son pill with 'an­ti-takeover ef­fect­s' af­ter in­vestor buy­out bid

3 years ago
Deals

Canaan lands $650M for lat­est VC fund aimed at tech and drug de­vel­op­ment

3 years ago
Financing
Startups

Ex-Cin­Cor CEO Marc de Garidel lands at Abi­vax af­ter ne­go­ti­at­ing $1.8B cash sale

3 years ago
People

Af­ter decades in Big Phar­ma, Kel­ly Page heads to 'growth stage'; Al­lied with No­var­tis, Bi­cy­cle se­lects de­vel­op­ment ...

3 years ago
Peer Review

Pfiz­er RSV da­ta set up $10B show­down with GSK and Mod­er­na for the next big vac­cine mar­ket

3 years ago
R&D
Pharma

Uptick in FDA ad­comms com­ing in 2023 as CDER hir­ing picks up, Cavaz­zoni says

3 years ago
FDA+

FDA is­sues draft guid­ance aimed at curb­ing man­u­fac­tur­ing short­ages

3 years ago
FDA+
Manufacturing

Rare rheuma­tol­ogy dis­ease in spot­light af­ter Sanofi, Re­gen­eron nab first drug ap­proval, more in pipeline po­ten­tials

3 years ago
Pharma
Marketing
First page Previous page 361362363364365366367 Next page Last page
A service from the Financial Times